Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-19-009301
Filing Date
2019-02-21
Accepted
2019-02-21 16:07:00
Documents
61
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tv513334_10k.htm 10-K 430929
2 EXHIBIT 10.28 tv513334_ex10-28.htm EX-10.28 162875
3 EXHIBIT 10.29 tv513334_ex10-29.htm EX-10.29 20745
4 EXHIBIT 21.1 tv513334_ex21-1.htm EX-21.1 2308
5 EXHIBIT 23.1 tv513334_ex23-1.htm EX-23.1 3445
6 EXHIBIT 31.1 tv513334_ex31-1.htm EX-31.1 11719
7 EXHIBIT 31.2 tv513334_ex31-2.htm EX-31.2 11487
8 EXHIBIT 32.1 tv513334_ex32-1.htm EX-32.1 4588
9 EXHIBIT 32.2 tv513334_ex32-2.htm EX-32.2 4610
  Complete submission text file 0001144204-19-009301.txt   3664184

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT enzn-20181231.xml EX-101.INS 877268
11 XBRL TAXONOMY EXTENSION SCHEMA enzn-20181231.xsd EX-101.SCH 31845
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20181231_cal.xml EX-101.CAL 26345
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20181231_def.xml EX-101.DEF 163378
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20181231_lab.xml EX-101.LAB 204975
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20181231_pre.xml EX-101.PRE 195153
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36435 | Film No.: 19621902
SIC: 2836 Biological Products, (No Diagnostic Substances)